Trials / Completed
CompletedNCT03856801
Acute Effects of Whole-body Vibration Training in Hypoxia and Normoxia in Multiple Sclerosis Patients
Acute Effects of Whole-body Vibration Training in Hypoxia and Normoxia Condition on Neuromuscular Performance and Mobility in Patients With Multiple Sclerosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Universidad Católica San Antonio de Murcia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Multiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease of the central nervous system, characterized by demyelination due to inflammation and degeneration of the myelin sheaths enveloping nerves of the eye, periventricular grey matter, brain, spinal cord and brainstem. The symptoms associated with MS include symptomatic fatigue, muscle weakness, ataxia, mobility and balance problems or cognitive problems. Moderate intensity strength training has been shown to improve strength and mobility in persons with MS. It was suggested that whole-body vibration training (WBVT) is effective to improve muscle strength, such as resistance training, resulting from both neural and structural adaptations. On the other hand, traditional strength training in hypoxia has garnered much attention. This method has shown improvements in isometric strength and increases in muscle size.
Detailed description
* Crossover. * 13 patients with multiple sclerosis were recruited. * Patients performed two sessions: whole-body vibration training in normoxia condition and whole-body vibration in hypoxia condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise | Whole-body vibration training in hypoxia and normoxia condition |
Timeline
- Start date
- 2018-06-15
- Primary completion
- 2018-07-30
- Completion
- 2018-08-30
- First posted
- 2019-02-27
- Last updated
- 2019-02-27
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03856801. Inclusion in this directory is not an endorsement.